... ReferencesTwo More People With HIV May Be Cured After Stem Cell Transplants — Aidsmap ...
... The increased risk for type 2 diabetes was equally high in all participants, regardless of whether they took the drug.The study builds on past research linking HIV to metabolic changes and unhealthy lipid levels, such as high triglycerides and low HDL cholesterol, which increase diabetes risk.How To Reduce Your Diabetes RiskIf you’re living with HIV ...
Preventing Diabetes With HIV: Study Reveals 4 Early Risks
... The increased risk for type 2 diabetes was equally high in all participants, regardless of whether they took the drug.The study builds on past research linking HIV to metabolic changes and unhealthy lipid levels, such as high triglycerides and low HDL cholesterol, which increase diabetes risk.How To Reduce Your Diabetes RiskIf you’re living with HIV ...
... Next steps usually include submitting the data to regulators such as the FDA, reviewing the full study results, and deciding whether the treatment can be approved and made available.If you’re interested in new options like this, your HIV specialist can help you understand whether a switch might make sense for your treatment history, including drug resistance ...
Once-Daily Tablet for HIV Works as Well as Multiple Pills in Phase 3 Studies
... Next steps usually include submitting the data to regulators such as the FDA, reviewing the full study results, and deciding whether the treatment can be approved and made available.If you’re interested in new options like this, your HIV specialist can help you understand whether a switch might make sense for your treatment history, including drug resistance ...
... This offsets one of the key benefits of taking just one extended-release injectable.Sunlenca is an HIV capsid inhibitor, approved by the FDA in December 2022. It works by disrupting the assembly and disassembly of HIV capsid (the protein shell of a virus), thereby preventing the virus from infecting cells and forming new viruses. ...
Injectables for HIV Treatment and Prevention: How They Work
... This offsets one of the key benefits of taking just one extended-release injectable.Sunlenca is an HIV capsid inhibitor, approved by the FDA in December 2022. It works by disrupting the assembly and disassembly of HIV capsid (the protein shell of a virus), thereby preventing the virus from infecting cells and forming new viruses. ...
... A study in the journal AIDS found that older people with HIV who experience fatigue often have trouble with thinking and memory. ...
... Lambda Legal HIV and Privacy Laws: What You Need To Know — PrEP Daily PrEP — Centers for Disease Control and Prevention Sharing Your Status — Be in the Know Disclosure of HIV-positive Status: Towards the Development of Guidelines, Strategies and Interventions — Rapid Response Service HIV Positive Status Disclosure to Sexual Partners: A Qualitative Study ...
Tips for Disclosing Your HIV Status to Others
... Lambda Legal HIV and Privacy Laws: What You Need To Know — PrEP Daily PrEP — Centers for Disease Control and Prevention Sharing Your Status — Be in the Know Disclosure of HIV-positive Status: Towards the Development of Guidelines, Strategies and Interventions — Rapid Response Service HIV Positive Status Disclosure to Sexual Partners: A Qualitative Study ...
Dating while living with the human immunodeficiency virus (HIV) can present unique challenges, b...
... This 2017 study looked at 130 people who were HIV-positive. Those who drank more caffeine were more likely to feel greater distress, experience a lower quality of life, and have worse insomnia. Interestingly, this study also had an association with negative outcomes related to CD4 count and viral load. ...
Caffeine and HIV: Should You Drink Coffee and Energy Drinks?
... This 2017 study looked at 130 people who were HIV-positive. Those who drank more caffeine were more likely to feel greater distress, experience a lower quality of life, and have worse insomnia. Interestingly, this study also had an association with negative outcomes related to CD4 count and viral load. ...
Many people associate HIV with weight loss. However, this is not always the case — especially now...
... According to a study in The Lancet, women with HIV are more likely to develop abnormal cervical cells that can lead to cancer and have a higher risk of those abnormal cells progressing to invasive cervical cancer. Treatments for invasive cervical cancer do not work as well in women with HIV as they do in women who are HIV-negative. ...
HIV Stages and Symptoms
... According to a study in The Lancet, women with HIV are more likely to develop abnormal cervical cells that can lead to cancer and have a higher risk of those abnormal cells progressing to invasive cervical cancer. Treatments for invasive cervical cancer do not work as well in women with HIV as they do in women who are HIV-negative. ...
Join
